INTERNATIONAL PATENT: GENFIT FILES APPLICATION FOR "INJECTABLE DOSAGE FORM OF 2-[6-(4-CYCLOPROPYL-4H-1,2,4-TRIAZOL-3-YL)-2-PYRIDYL]-5-MORPHOLINOCARBONYL-1-ISOINDOLINONE"

GENEVA, March 23 -- GENFIT (885 avenue Eugene Avinee59120 LOOS) filed a patent application (PCT/EP2025/076078) for "INJECTABLE DOSAGE FORM OF 2-[6-(4-CYCLOPROPYL-4H-1,2,4-TRIAZOL-3-YL)-2-PYRIDYL]-5-MORPHOLINOCARBONYL-1-ISOINDOLINONE" on Sep 12, 2025. With publication no. WO/2026/057806, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JOISSAINS, Marie-Jeanne (4, An Daou Barz29700 PLOMELIN), THIBOUT, Paul (4 rue Alexandre Desrousseaux59800 LILLE)

Abstract: The present invention relates to an injectable form comprising: (i)...